John Hancock Life Insurance After a Heart Attack Fit Review

Research Snapshot

Why John Hancock Qualified for This Study

Questions This Section Answers

• Why did John Hancock qualify for a life insurance after a heart attack comparison if only 3 of 7 platforms named it?
• Is John Hancock a mainstream carrier worth comparing for a post-heart-attack applicant?

John Hancock qualified because it met the study's minimum-mention threshold and because multiple platforms independently identified it as a carrier worth evaluating for cardiac histories. It was named by three of seven platforms during ranking discovery — anthropic, google, and kimi — which is 42.9% of included platform responses. Its average listed rank was 7.67, with a best rank of 5 from google.

Qualification does not mean consensus. The three platforms that named John Hancock placed it mid-to-low in their lists, and the four platforms that did not name it during ranking still evaluated its fit afterward. Fit ratings across all seven platforms were split: anthropic, google, and grok rated it a good fit; openai, perplexity, and deepseek rated it mixed; kimi rated it uncertain.

One qualification note matters for interpretation. The deterministic identity audit records that official-site retrieval failed during the ranking stage and that the entity was matched using an exact-name fallback, with the reported domain retained but unverified. The audit also notes that company-name variants were collapsed onto one canonical brand before the minimum-mentions threshold was applied. Buyers should treat the ranking placement as platform-reported rather than independently confirmed.

The Product, Model, Plan, or Service Most Relevant to Life Insurance After a Heart Attack

Questions This Section Answers

• Which John Hancock policy should a post-heart-attack buyer actually apply for — Term with Vitality, Protection UL, or Simple Term with Vitality?
• Is John Hancock Simple Term with Vitality available to an applicant with a prior heart attack?

The most relevant John Hancock option for this use case is fully underwritten coverage: John Hancock Term with Vitality or Protection UL with Vitality. Simple Term with Vitality is not the right product for this buyer, because John Hancock's own underwriting guide states that Simple Term with Vitality is not eligible for coronary disorder or vascular disease, including a history of heart attack, stent placement, or cardiomyopathy ^[4].

Platforms described the relevant product differently, and that conflict should be disclosed rather than smoothed over. Anthropic named Protection UL with Vitality, Term with Vitality, and Vitality Term. Google named Protection UL and Vitality Term/UL with HealthStyles. Grok named Protection UL or Term with Vitality. Kimi named Protection UL or Term with Vitality plus term and whole life. OpenAI named term life with Vitality PLUS and noted that Protection UL may be considered after full underwriting. Deepseek named Vitality term and Protection UL while also stating that traditional term and whole life are marketed.

Two of those descriptions conflict with other evidence. Kimi listed whole life as a relevant product, but anthropic's sources state John Hancock does not offer whole life insurance ^[5]. Deepseek also listed whole life as marketed ^[7]. No platform located a publicly verified John Hancock cardiac-specific product or heart-attack underwriting table (openai, perplexity, deepseek, kimi).

Term durations shown by John Hancock are 10, 15, 20, or 30 years, with 30-year term unavailable in New York ^[8]. Term coverage ranges from $250,000 to $30 million according to one independent review ^[10]. Protection UL is described as low-cost guaranteed death benefit protection to age 121 ^[11].

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree on about John Hancock for life insurance after a heart attack?
• Does John Hancock's Vitality program help a post-heart-attack life insurance applicant?

Platforms agreed on four points, though not unanimously on all of them.

First, John Hancock sells mainstream fully underwritten term and permanent coverage that a stable post-heart-attack applicant could theoretically be considered for. OpenAI, anthropic, perplexity, and deepseek all described fully underwritten term or permanent options as the relevant path, with no platform claiming a guaranteed-issue cardiac product.

Second, Vitality is a real, documented feature tied to eligible policies. John Hancock Vitality rewards verified physical activity, nutrition, and preventive screenings, and verified activity can lead to premium savings ^[12]. John Hancock advertises up to 25% premium savings with Vitality PLUS, subject to underwriting status, issue age, product, policy terms, and Vitality status ^[15].

Third, a prior heart attack triggers individualized medical underwriting rather than automatic approval. John Hancock states that policy issuance is not guaranteed and that applications are subject to health questions, underwriting approval, and possible medical-record review ^[18]. Independent guidance identifies time since the myocardial infarction, recovery, current cardiac stability, medications, ejection fraction, stress-test or echocardiogram results, intervention history, and follow-up documentation as material considerations ^[19].

Fourth, John Hancock maintains strong financial-strength ratings. One independent review lists A.M. Best A+, Moody's A1, S&P AA-, and Fitch AA ^[22]. Deepseek cautioned that current third-party ratings should be verified directly with the rating agencies rather than taken from marketing pages (deepseek).

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• Does John Hancock have a documented post-heart-attack waiting period or cardiac rating table?
• Is John Hancock's atrial fibrillation specialty focus after a heart attack verified?

The largest disagreement is whether John Hancock has any cardiac underwriting advantage at all. Google reported detailed coronary artery disease classes from a retrieved field underwriting guide: Class 1 CAD (one-vessel disease, ejection fraction above 55%) rated at 175% of base premium under age 50, 150% at ages 50–59, Standard at 60–70, and Preferred at 71–90 ^[23]. Class 2 CAD (two-vessel disease, ejection fraction 50–55%) was rated 225% under age 50, 150–175% at ages 50–70, and Standard at 71–90 ^[24]. Class 3 CAD was rated 300% to decline under age 50 and 225% at ages 50–69 ^[25].

No other platform retrieved comparable John Hancock-specific cardiac rating detail. OpenAI, perplexity, deepseek, and kimi each stated that no verified public John Hancock cardiac underwriting table, post-MI acceptance rate, or typical table rating was located. Perplexity noted that publicly verifiable John Hancock-specific post-heart-attack acceptance criteria — waiting period, ejection fraction thresholds, stress-test requirements, or exact rating classes — were not clearly confirmed in the sources it checked.

Waiting-period claims also conflict. Grok stated that John Hancock typically considers applicants 12–24 months post-event with Table 3–5 ratings common ^[26]. Google reported a general 6-to-12-month stabilization period for traditional coverage, sourced to an independent guide rather than to John Hancock ^[27]. OpenAI stated that no verified public John Hancock rule states how long after a heart attack an applicant must wait. Deepseek stated that a recent heart attack within roughly 6–12 months makes approval unlikely at most mainstream carriers.

The atrial fibrillation claim is unverified. The ranking-stage description referenced a John Hancock specialty focus on atrial fibrillation, but deepseek, perplexity, and kimi each reported that no John Hancock public source confirms AFib-specific positioning. Anthropic cited independent reviews stating John Hancock takes a modern view of controlled atrial fibrillation ^[28], but those are third-party characterizations, not carrier-published guidelines.

One platform reported a specific case outcome. Grok stated that in shopped cases, John Hancock offered Table 4 or Table 5 ratings for post-MI applicants with stents or bypass ^[30]. That is a single platform-reported observation and should not be treated as a general acceptance pattern.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What cardiac underwriting factors does John Hancock evaluate for a post-heart-attack life insurance applicant?
• Does John Hancock's Vitality program reduce premiums for a table-rated post-heart-attack policy?

The features most relevant to this use case are underwriting depth, the Vitality wellness program, and conversion rights.

On underwriting depth, John Hancock's underwriting guide calls for Attending Physician Statement records and notes that additional exams, bloodwork, EKG, or telephone interviews may be requested at underwriter discretion ^[31]. A field underwriting guide references a five-year medical history and primary-physician APS review ^[32]. Independent guidance describes the cardiac factors underwriters weigh: time since the event, ejection fraction, stress tests, stent or bypass history, medication compliance, and cardiologist follow-up notes ^[33].

On Vitality, John Hancock advertises up to 25% premium savings with Vitality PLUS, conditional on underwriting status, issue age, product, policy terms, and Vitality status ^[36]. Vitality GO is described as included at no additional cost where available, but it is not available in New York ^[37]. One platform noted that whether Vitality discounts apply to substandard-rated cardiac policies is unverified (kimi). Another noted that Vitality status resets annually, so discounts must be re-earned each policy year (anthropic).

On conversion, John Hancock term policies are described as convertible to permanent coverage without new underwriting if converted within the lesser of the level term period or age 70 ^[38]. One platform flagged that whether underwriting is required for an increase in face amount upon conversion is not consistently stated across sources (anthropic).

On accelerated underwriting, SmartProtect Term with Vitality offers streamlined decisions in as little as two days with no medical screenings, tests, or telephone interviews, limited to ages 20–60 at $100,000–$1,000,000 ^[41]. Multiple platforms stated this pathway is unsuitable for post-heart-attack applicants because simplified underwriting excludes the detailed medical review a cardiac case requires (anthropic, perplexity, deepseek).

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does John Hancock term life insurance with Vitality cost per month for a post-heart-attack applicant?
• What fees and contract terms should a post-heart-attack buyer confirm before signing a John Hancock policy?

No platform verified a John Hancock premium for a post-heart-attack applicant. Pricing confidence was rated low by openai, anthropic, deepseek, perplexity, and kimi; google rated it high based on retrieved rating-class percentages.

The only John Hancock-specific cost figures in the evidence are conditional. John Hancock's FAQ states that, for term policies with the optional Vitality rider, Vitality PLUS costs 3% of annual premium ^[43]. Other John Hancock pages describe Vitality PLUS as available for as little as $2 per month or sometimes included in policy pricing ^[44]. This is a direct conflict between company-owned pages, and the applicable amount depends on product, rider, state, and policy form.

Baseline pricing benchmarks are for standard profiles, not cardiac applicants. One independent review reported that a 40-year-old nonsmoker in average health pays about $9/month (female) to $11/month (male) for $100,000 of 20-year term, roughly 40–43% below the national average for that profile ^[45]. Another reported an average annual premium of roughly $349, about 9% below the industry average ^[47]. Both sources note the pricing advantage narrows as coverage increases, moving 6–7% above industry average at $1.5–2 million ^[48].

Post-heart-attack pricing would be set by underwriting class, not by these standard-profile benchmarks. Google's retrieved rating classes imply percentage rate-ups of 150% to 300%+ of base premium depending on CAD class and age, or decline ^[50]. Grok stated that a Table 4 rating adds roughly 50–100% to standard (grok). Kimi cited market benchmarks for substandard classes — approximately $52–66/month for $500,000 of term for a well-managed 40-year-old — but noted those are market averages, not John Hancock-specific ^[53].

Contract terms to verify include term length and renewal or conversion provisions governed by the policy contract ^[54], lapse risk on universal life if loans plus interest exceed cash value (anthropic), and the fact that Vitality rewards and discounts may change and are not guaranteed for the life of the policy (openai). Perplexity noted that no verified public post-issue cancellation or free-look terms specific to these products were found in the sources it checked.

Best Suited For

Questions This Section Answers

• Who is John Hancock best suited for among life insurance buyers with a prior heart attack?
• Is John Hancock a good choice for an older heart attack survivor with single-vessel disease?

John Hancock is best suited for a narrow slice of post-heart-attack buyers: those with a remote, stable, well-documented event who want conventional fully underwritten term or permanent coverage and who may value Vitality.

Platforms converged on similar profiles. OpenAI described applicants whose heart attack was sufficiently long ago for the carrier to consider the case, with stable follow-up records, favorable cardiac testing, controlled risk factors, and a need for traditional term or permanent coverage. Anthropic described applicants 3+ months post-MI with stable recovery and normal ejection fraction, on appropriate cardiac medications with good compliance, aged 35–65. Grok described applicants 12+ months post-MI with stable recovery and lifestyle improvements. Deepseek described buyers who have made durable, documentable lifestyle changes and are willing to share activity and biometric data. Google described older survivors (ages 60–90) with high cardiac function, including Class 1 CAD applicants who could reach Standard or even Preferred rates ^[55].

The strongest documented case for John Hancock in this study is the age-favorable rating structure google retrieved: Class 1 CAD applicants aged 60–70 may qualify for Standard rates and those aged 71–90 for Preferred rates ^[55]. That is a specific, retrievable underwriting guideline, though it comes from a field underwriting guide rather than a consumer-facing John Hancock page.

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose John Hancock for life insurance after a heart attack?
• Is John Hancock a bad choice for a buyer with a recent heart attack or multiple cardiac events?

John Hancock is probably not the best fit for several post-heart-attack buyer profiles, and platforms were more aligned on exclusions than on advantages.

Buyers with a recent heart attack are poorly matched. OpenAI stated that a recent or medically complex cardiac history may produce postponement, decline, exclusions or limitations where permitted, or a substantially higher premium. Deepseek stated that a recent heart attack within roughly 6–12 months makes approval unlikely at most mainstream carriers. Grok stated postponement is likely under 12 months post-MI. Google reported a general 6-to-12-month stabilization period ^[56].

Buyers with severe or complicated cardiac histories are also poorly matched. Anthropic listed ejection fraction below 35%, congestive heart failure, and uncontrolled arrhythmias as profiles likely to be delayed or declined. Google reported that multiple heart attacks generally result in uninsurable status for standard life products ^[57], and that Class 3 CAD applicants under age 50 are rated 300% or declined ^[58].

Buyers seeking guaranteed or simplified issue are not served here. Perplexity stated that Simple Term with Vitality excludes anyone with a heart attack history ^[59]. Kimi stated that John Hancock does not appear in guaranteed-issue life insurance discussions for heart patients and likely offers no fallback option for declined applicants. OpenAI stated that buyers seeking guaranteed acceptance or no-medical-exam coverage specifically designed for post-heart-attack applicants should look elsewhere.

Buyers who want whole life are also excluded. Anthropic's sources state John Hancock does not offer whole life insurance ^[60], though kimi and deepseek listed whole life as marketed — a conflict buyers should resolve directly with the carrier.

Finally, buyers who would not use Vitality enough to justify its rider fee, or who prefer predictable premiums without program requirements, are poorly matched (openai). One platform also flagged customer-service friction: phone-only support during business hours, no email or live chat, and a BBB rating of C with 100+ complaints in the past three years ^[61].

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to John Hancock for a post-heart-attack buyer who needs published cardiac underwriting guidelines?
• When should a post-heart-attack buyer use an independent broker instead of applying directly to John Hancock?

Another option may be better in four situations that platforms described consistently.

When the buyer needs published, transparent cardiac underwriting grids. Kimi reported that Protective Life, Banner Life/Legal & General, Prudential, Pacific Life, Transamerica, North American, Lincoln Financial, and Mutual of Omaha publish explicit post-MI postponement periods and table rating structures, while John Hancock does not appear in those comparison tables ^[62]. Anthropic similarly named Lincoln Financial, Protective, and Banner as carriers with published guidelines specifically designed for MI applicants.

When the heart attack was recent or cardiac status is unstable. OpenAI recommended a cardiac-focused independent broker when the event was recent, involved bypass surgery or multiple stents, involved reduced ejection fraction, or includes atrial fibrillation or other ongoing cardiac conditions. Deepseek recommended waiting and reapplying, or using a carrier with documented post-MI underwriting.

When the buyer needs guaranteed issue or simplified issue. Kimi cited Mutual of Omaha's guaranteed-issue whole life for ages 45–85 with no health questions or medical exams and a one-to-two-year graded benefit period ^[63]. OpenAI noted these products commonly have lower limits, higher cost, graded benefits, or waiting-period provisions that must be reviewed.

When the buyer wants the lowest absolute premium rather than wellness-linked discounts. Anthropic stated that some competitors price more aggressively for standard classifications and that Vitality savings may not offset a base-rate difference. Moneygeek's review found John Hancock's pricing advantage narrows as coverage increases ^[64].

Across all four situations, the recurring recommendation was to compare carriers through an independent agent and use informal or pre-underwriting before submitting a formal application, so a decline is not recorded unnecessarily (openai, anthropic, deepseek).

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer confirm with John Hancock before signing a post-heart-attack life insurance contract?
• Which cardiac records will John Hancock require before making an underwriting decision?

Platforms supplied overlapping verification lists. The consolidated items below combine them; each should be confirmed with a licensed agent and, where possible, in writing.

• How long after this applicant's specific heart attack will John Hancock consider an application, and would the case be postponed because of its date? (openai, anthropic, deepseek, kimi)
• Will John Hancock evaluate this case informally before a formal application, and can the agent obtain a likely underwriting class or preliminary decision? (openai, anthropic)
• Which records are required: hospitalization and catheterization reports, discharge summary, cardiologist notes, medication list, ECG, echocardiogram with ejection fraction, stress test, and laboratory results? (openai, perplexity, kimi)
• What ejection fraction threshold exists for approval, and will applicants below it be approved, declined, or require special underwriting? (anthropic, kimi)
• How do the event's age, number of affected vessels, stents or bypass surgery, current symptoms, ejection fraction, arrhythmias or AFib, medications, smoking status, blood pressure, cholesterol, diabetes, and rehabilitation affect eligibility and rating? (openai, anthropic)
• Is the recommended policy Term with Vitality PLUS, Protection UL with Vitality, or another policy form, and what are the guaranteed premiums, nonguaranteed assumptions, surrender charges, and lapse risks? (openai, perplexity)
• What exact Vitality rider fee applies in the buyer's state — 3% of annual premium, $2 per month, or included in policy cost — and what activities or health review are required? ^[66]
• Is the policy available in the buyer's state, and are there state-specific differences in term length, riders, Vitality GO, conversion, or exclusions? (openai, anthropic)
• What are the renewal, conversion, reinstatement, contestability, suicide, accelerated-benefit, and cancellation terms? (openai, deepseek)
• How does John Hancock's quote compare with at least two carriers known by the broker to consider post-heart-attack cases? (openai, anthropic, kimi)

Final AI Consensus Verdict

John Hancock is a mixed fit for life insurance after a heart attack, and the split is genuine rather than a rounding error. Three platforms rated it good, three rated it mixed, and one rated it uncertain. Three of seven platforms named it during ranking discovery, at an average listed rank of 7.67.

The case for considering it rests on one retrievable underwriting document showing structured CAD rating classes with age-favorable treatment for older applicants ^[68], plus a documented Vitality program that can reward verified healthy behavior with conditional premium savings ^[70]. The case against treating it as a cardiac specialist rests on the absence of any verified John Hancock post-heart-attack waiting period, acceptance rate, or cardiac rating table across four platforms, and on the fact that John Hancock's own underwriting guide excludes heart attack history from Simple Term with Vitality ^[72].

The practical conclusion is that John Hancock belongs in a multi-carrier comparison run by an independent agent, particularly for an older applicant with a single, remote, well-documented event and preserved heart function. It should not be treated as a purpose-built post-heart-attack carrier, and buyers with recent, complicated, or poorly documented cardiac histories should compare carriers with published cardiac underwriting grids before applying. Platform agreement in this study reflects how AI systems described John Hancock, not verified product quality or a guaranteed underwriting outcome.

How This Review Was Produced

This review synthesizes fit-research responses from seven AI platforms — anthropic, deepseek, google, grok, kimi, openai, and perplexity — each of which independently evaluated John Hancock for the use case of life insurance after a heart attack. The study used the run research date of 2026-09-22 as the authoritative study date.

Platform mentions in the ranking stage count only platforms that named John Hancock during ranking discovery, which was three of seven. All seven platforms evaluated fit afterward, and their fit ratings are reported separately from ranking mentions. Citations are platform-reported evidence, not independently verified facts. Where a platform supplied no citation for a factual claim, that claim is labeled platform-reported or unverified rather than presented as established.

The two internal reference points for this study are the Life Insurance After a Heart Attack consensus index and the broader life insurance category directory.

Methodology Limitations

Several limitations apply to this review and should be weighed before acting on it.

Platform-reported research dates differ from the authoritative run date. Deepseek reported 2026-02-14, while the run research date is 2026-09-22. Platform-reported dates are provenance metadata and do not independently prove freshness.

Official-site retrieval failed during the ranking stage. The deterministic identity audit records that the official domain returned an HTTP 403 and that the entity was matched using an exact-name fallback, with the reported domain retained but unverified. The audit also notes that company-name variants were collapsed onto one canonical brand before the minimum-mentions threshold was applied.

The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts. No-search model claims require explicit verification before being described as current facts; deepseek ran with search disabled.

Conflicting product names, pricing, and capabilities were not resolved by guessing. Where platforms disagreed — on whole life availability, on Vitality PLUS cost, on waiting periods, and on atrial fibrillation positioning — the conflict is described and the buyer is directed to verify.

No platform located a publicly verified John Hancock cardiac-specific product, heart-attack underwriting table, post-MI acceptance rate, or guaranteed waiting period. Absence of a retrieved document is not proof that no such program exists; it means the evidence was not available in this study.